ProText
Connective Tissue Supplementation (Homologous Use)
Key Facts
About Regenative Labs
Regenative Labs is a private, commercial-stage biotechnology company specializing in structural tissue allografts regulated under the FDA's 361 HCT/P pathway. The company leverages human birth tissue, primarily Wharton's Jelly from the umbilical cord, to create a portfolio of products (CryoText, SecreText, ProText, AmnioText) for orthopedic, sports medicine, and aesthetic applications. It operates with a B2B model, partnering directly with physicians and providers, and manufactures its products in an ISO Class 5 cleanroom facility. The company is actively generating revenue, publishing clinical case studies, and positioning itself in the growing market for regenerative alternatives to invasive surgery and opioids.
View full company profile